Merck, Nastech develop obesity drug
17811
Nastech shares jump before the bell after companies say they will jointly create the new treatment. NEW YORK  - Merck &amp; Co.
767024
It makes a fat body think like a lean person, say the Australian developers of a new bulge-busting drug. Biotechnology firm Metabolic Pharmaceuticals said the obesity drug, code-named AOD9604, was unique in that it stimulated the metabolism of body fat.
171351
Melbourne-based biotechnology company Metabolic Pharmaceuticals says it has successfully completed a Phase 2b human trial on a drug which stimulates the metabolism of body fat.
237818
By altering a gene, scientists have produced "marathon mice" with more muscle, less fat, and twice the endurance of regular mice. The find could lead to new anti-obesity drugs.
379753
Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and aims to have another four products in late-stage trials by midyear, the company said on Tuesday.
150142
TRENTON, NJ - Two drug companies announced Monday they will collaborate on developing the first all-in-one, once-a-day pill to treat HIV infection - a long-sought goal that would make it much easier for patients to stick with their medication.
181860
Platforms have the potential to develop multiple drugs for a company.
616847
NEW YORK To people who have struggled for a lifetime to lose weight, the new drug called rimonabant sounds like a dream come true.
727152
New developments are brewing at the pharmaceutical.
208543
Vioxx was already a big success as an arthritis pain reliever, but Merck &amp; Co. thought it could be an even bigger seller. The drug seemed to have some cancer-prevention qualities
373155
Merck has obtained rights to license an experimental drug to treat obesity that has generated scientific interest because it is based on a hormone used by the body to signal that it has eaten enough.
403138
NEW ORLEANS - An experimental pill that offers the promise of helping people lose weight and quit smoking has raised more expectations.
384058
AN Australian company has developed the first weight-loss pill that kick-starts the human body&#39;s metabolism to help people burn fat without the need for strict diets or exercise.
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
157645
Biotechnology company Rigel  Pharmaceuticals Inc. RIGL.O has entered into a collaboration  pact with drugmaker Merck & Co. Inc. MRK.N to find treatments  for cancer and potentially other diseases, Rigel said on  Monday.
482801
A new obesity wonder drug, Acomplia (rimonabant), makes patients lose 10% of their body weight, according to clinical trials carried out by Sanofi-Aventis, the third largest pharmaceutical company in the world.
575085
NEW YORK/FRANKFURT  - A drug being developed by  Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some  liver cancer patients and temporarily stabilized the disease in  others in a small clinical trial, the companies said on  Wednesday.